Trials / Completed
CompletedNCT05533281
Efficacy of Three Antiemetics in Preventing Nausea and Vomiting
Observation on the Efficacy of Three Antiemetics in Preventing Nausea and Vomiting Caused by Intravenous Tramadol Injection and Postoperative Nausea and Vomiting
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- The Second Affiliated Hospital of Chongqing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To explore the effect of commonly used antiemetic drugs on reducing nausea and vomiting caused by intravenous tramadol injection, so as to reduce the incidence of nausea and vomiting in clinical use of tramadol and provide guidance for the clinical use of tramadol injection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tropisetron | One tropisetron was given 30 minutes in advance, and then tramadol 1.5mg/kg was intravenously injected with a micropump at a constant speed. |
| DRUG | metoclopramide | One dose of metoclopramide was given 30 minutes in advance, and then tramadol 1.5mg/kg was injected intravenously with a micropump at a constant speed. |
| DRUG | dexamethasone | One dose of dexamethasone was given 30 minutes in advance, and then tramadol 1.5mg/kg was injected intravenously with a micropump at a constant speed. |
| OTHER | normal saline | Equal dose of normal saline was given 30 minutes in advance, and then tramadol 1.5mg/kg was injected intravenously with a micropump at a constant speed. |
Timeline
- Start date
- 2022-09-15
- Primary completion
- 2023-10-30
- Completion
- 2023-11-03
- First posted
- 2022-09-09
- Last updated
- 2024-04-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05533281. Inclusion in this directory is not an endorsement.